MX2016010385A - Agentes antibacterianos. - Google Patents
Agentes antibacterianos.Info
- Publication number
- MX2016010385A MX2016010385A MX2016010385A MX2016010385A MX2016010385A MX 2016010385 A MX2016010385 A MX 2016010385A MX 2016010385 A MX2016010385 A MX 2016010385A MX 2016010385 A MX2016010385 A MX 2016010385A MX 2016010385 A MX2016010385 A MX 2016010385A
- Authority
- MX
- Mexico
- Prior art keywords
- agents
- antibacterial agents
- vancomycin
- acetyl
- animals
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical group NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 abstract 1
- 108010013639 Peptidoglycan Proteins 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a agentes con actividad antibacteriana, su producción y uso en el tratamiento de infecciones bacterianas en animales, que incluye el hombre. Los agentes son derivados de antibióticos tipo vancomicina, de estructura X-W-L-V, en donde X es hidrógeno, acetilo o un elemento lipofílico que se inserta en la membrana, W es un péptido básico o aminoácido básico; L es un grupo ligador y V es una porción glicopéptido que inhibe la biosíntesis del peptidoglicano en una bacteria.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1402267.7A GB201402267D0 (en) | 2014-02-10 | 2014-02-10 | Antibacterial agents |
| PCT/AU2015/000071 WO2015117196A1 (en) | 2014-02-10 | 2015-02-10 | Antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016010385A true MX2016010385A (es) | 2017-05-12 |
Family
ID=50390736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016010385A MX2016010385A (es) | 2014-02-10 | 2015-02-10 | Agentes antibacterianos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10947271B2 (es) |
| EP (1) | EP3105244B1 (es) |
| JP (1) | JP6602318B2 (es) |
| CN (1) | CN107027309B (es) |
| AU (1) | AU2015213478B2 (es) |
| BR (1) | BR112016018442A2 (es) |
| CA (1) | CA2939145C (es) |
| GB (1) | GB201402267D0 (es) |
| MX (1) | MX2016010385A (es) |
| RU (1) | RU2016134602A (es) |
| WO (1) | WO2015117196A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| US20200078466A1 (en) * | 2016-12-09 | 2020-03-12 | The University Of Queensland | Glycopeptide antibiotic constructs |
| WO2018102890A1 (en) * | 2016-12-09 | 2018-06-14 | The University Of Queensland | Visualization constructs |
| NZ758839A (en) | 2017-05-22 | 2025-08-29 | Insmed Inc | Glycopeptide derivative compounds and uses thereof |
| CN108060207B (zh) * | 2017-12-29 | 2021-10-15 | 河南科技大学 | 一种基于微量天然化合物的最小杀菌浓度测定方法 |
| CN109946398B (zh) * | 2019-03-28 | 2022-05-24 | 丽珠集团新北江制药股份有限公司 | 一种检测达巴万星及其杂质的方法 |
| CN116515102B (zh) * | 2022-01-21 | 2025-04-18 | 苏州万维生命科学技术有限公司 | 星型β-抗菌糖肽、其制备方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840684A (en) | 1994-01-28 | 1998-11-24 | Eli Lilly And Company | Glycopeptide antibiotic derivatives |
| GB9614871D0 (en) | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
| EP0926955A4 (en) | 1996-09-12 | 2003-05-07 | Merck & Co Inc | Conjugates useful in the treatment of prostate cancer |
| US6017511A (en) | 1997-05-30 | 2000-01-25 | Resolution Pharmaceuticals Inc. | Glycopeptide-chelator conjugates |
| ZA991410B (en) | 1998-02-23 | 1999-10-06 | Synsorb Biotech Inc | Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions. |
| JP4381531B2 (ja) * | 1999-12-08 | 2009-12-09 | 塩野義製薬株式会社 | グリコペプチド誘導体 |
| US6770621B2 (en) | 2000-05-02 | 2004-08-03 | Theravance, Inc. | Polyacid glycopeptide derivatives |
| AU2001278933B2 (en) | 2000-07-17 | 2006-05-25 | Migenix Inc. | Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| GB0026924D0 (en) * | 2000-11-03 | 2000-12-20 | Univ Cambridge Tech | Antibacterial agents |
| GB0220936D0 (en) * | 2002-09-05 | 2002-10-23 | Adprotech Ltd | Modified therapeutic agents |
| AU2003287605A1 (en) | 2002-11-12 | 2004-06-03 | Enzon Pharmaceuticals, Inc. | Polymeric prodrugs of vancomycin |
| WO2007047608A2 (en) | 2005-10-14 | 2007-04-26 | Epix Pharmaceuticals, Inc. | Fibrin targeted therapeutics |
| WO2007103548A2 (en) | 2006-03-09 | 2007-09-13 | Inflazyme Pharmaceuticals Ltd. | Novel antibiotic compositions |
| CN102264756B (zh) * | 2008-10-23 | 2014-08-06 | 斯特巴生物技术有限公司 | 含rgd的拟肽和其用途 |
| WO2011019839A2 (en) | 2009-08-12 | 2011-02-17 | The Medicines Company | Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
-
2014
- 2014-02-10 GB GBGB1402267.7A patent/GB201402267D0/en not_active Ceased
-
2015
- 2015-02-10 RU RU2016134602A patent/RU2016134602A/ru not_active Application Discontinuation
- 2015-02-10 CN CN201580018660.5A patent/CN107027309B/zh not_active Expired - Fee Related
- 2015-02-10 MX MX2016010385A patent/MX2016010385A/es unknown
- 2015-02-10 JP JP2016568088A patent/JP6602318B2/ja active Active
- 2015-02-10 US US15/117,704 patent/US10947271B2/en active Active
- 2015-02-10 BR BR112016018442A patent/BR112016018442A2/pt not_active Application Discontinuation
- 2015-02-10 CA CA2939145A patent/CA2939145C/en active Active
- 2015-02-10 WO PCT/AU2015/000071 patent/WO2015117196A1/en not_active Ceased
- 2015-02-10 EP EP15746637.6A patent/EP3105244B1/en active Active
- 2015-02-10 AU AU2015213478A patent/AU2015213478B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016134602A (ru) | 2018-03-15 |
| BR112016018442A2 (pt) | 2018-05-08 |
| WO2015117196A1 (en) | 2015-08-13 |
| CA2939145C (en) | 2024-05-07 |
| AU2015213478B2 (en) | 2019-08-08 |
| US10947271B2 (en) | 2021-03-16 |
| US20170204138A1 (en) | 2017-07-20 |
| CN107027309A (zh) | 2017-08-08 |
| CA2939145A1 (en) | 2015-08-13 |
| AU2015213478A2 (en) | 2016-09-15 |
| EP3105244A4 (en) | 2017-11-08 |
| GB201402267D0 (en) | 2014-03-26 |
| EP3105244B1 (en) | 2020-01-01 |
| JP6602318B2 (ja) | 2019-11-06 |
| EP3105244A1 (en) | 2016-12-21 |
| AU2015213478A1 (en) | 2016-09-15 |
| CN107027309B (zh) | 2021-10-01 |
| JP2017507174A (ja) | 2017-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016010385A (es) | Agentes antibacterianos. | |
| MX2024009339A (es) | Biomarcadores utiles en el diagnostico de infecciones bacterianas y virales. | |
| NZ618571A (en) | Peptides and their use | |
| EP3483259A4 (en) | NOVEL MILK ACID BACTERIA AND USE THEREOF | |
| WO2016108045A3 (en) | Antimicrobial compounds, compositions and methods | |
| MX2018001075A (es) | Agentes terapeuticos y profilacticos antibacterianos. | |
| PH12016500207A1 (en) | Anti-infective compounds | |
| WO2016142445A3 (en) | Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection | |
| NZ630117A (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
| NZ728429A (en) | Acinetobacter lysins | |
| MX2019007613A (es) | Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos. | |
| MX2016015218A (es) | Antibioticos macrociclicos de amplio espectro. | |
| CL2016001524A1 (es) | Derivados antibacterianos de 1h-indazol y 1h-indol. | |
| EP3875576A4 (en) | NOVEL LACTIC ACID BACTERIA AND USE THEREOF | |
| EP3903823A3 (en) | Antimicrobial peptides and methods of use thereof | |
| MX378754B (es) | Métodos y reactivos para la prevención y/o el tratamiento de infecciones. | |
| ITUA20162013A1 (it) | Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica. | |
| MX2016007626A (es) | Peptido antimicrobiano y usos del mismo. | |
| MX2019006768A (es) | Peptidos antimicrobianos. | |
| MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
| PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
| IL277399A (en) | Antimicrobial polypeptides produced from bacteriophage and their use against gram-negative bacteria | |
| CL2017001276A1 (es) | Derivados de benzotiazol antibacterianos | |
| PH12016501532A1 (en) | Antibacterial combinations comprising polymyxin | |
| WO2015130547A8 (en) | Bis-cyclic guanidine compound compositions, methods of use and treatment thereof |